North America Alzheimer’s Disease Drug Market by Manufacturers, Countries, Type and Application, Forecast to 2022

1 Market Overview

1.1 Alzheimer’s Disease Drug Introduction

1.2 Market Analysis by Type

1.2.1 Donepezil

1.2.2 Memantine

1.2.3 Rivastigmine

1.3 Market Analysis by Applications

1.3.1 Early to Moderate Stages

1.3.2 Moderate to Severe Stages

1.4 Market Analysis by Countries

1.4.1 United States Status and Prospect (2012-2022)

1.4.2 Mexico Status and Prospect (2012-2022)

1.4.3 Canada Status and Prospect (2012-2022)

1.5 Market Dynamics

1.5.1 Market Opportunities

1.5.2 Market Risk

1.5.3 Market Driving Force

2 Manufacturers Profiles

2.1 Allergan

2.1.1 Profile

2.1.2 Alzheimer’s Disease Drug Type and Applications

2.1.2.1 Type 1

2.1.2.2 Type 2

2.1.3 Allergan Alzheimer’s Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.1.4 Business Overview

2.1.5 Allergan News

2.2 Eisai

2.2.1 Profile

2.2.2 Alzheimer’s Disease Drug Type and Applications

2.2.2.1 Type 1

2.2.2.2 Type 2

2.2.3 Eisai Alzheimer’s Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.2.4 Business Overview

2.2.5 Eisai News

2.3 Novartis

2.3.1 Profile

2.3.2 Alzheimer’s Disease Drug Type and Applications

2.3.2.1 Type 1

2.3.2.2 Type 2

2.3.3 Novartis Alzheimer’s Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.3.4 Business Overview

2.3.5 Novartis News

2.4 Daiichi Sankyo

2.4.1 Profile

2.4.2 Alzheimer’s Disease Drug Type and Applications

2.4.2.1 Type 1

2.4.2.2 Type 2

2.4.3 Daiichi Sankyo Alzheimer’s Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.4.4 Business Overview

2.4.5 Daiichi Sankyo News

2.5 Merz Pharma

2.5.1 Profile

2.5.2 Alzheimer’s Disease Drug Type and Applications

2.5.2.1 Type 1

2.5.2.2 Type 2

2.5.3 Merz Pharma Alzheimer’s Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.5.4 Business Overview

2.5.5 Merz Pharma News

2.6 Pfizer

2.6.1 Profile

2.6.2 Alzheimer’s Disease Drug Type and Applications

2.6.2.1 Type 1

2.6.2.2 Type 2

2.6.3 Pfizer Alzheimer’s Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.6.4 Business Overview

2.6.5 Pfizer News

2.7 Johnson & Johnson

2.7.1 Profile

2.7.2 Alzheimer’s Disease Drug Type and Applications

2.7.2.1 Type 1

2.7.2.2 Type 2

2.7.3 Johnson & Johnson Alzheimer’s Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.7.4 Business Overview

2.7.5 Johnson & Johnson News

2.8 Lundbeck.

2.8.1 Profile

2.8.2 Alzheimer’s Disease Drug Type and Applications

2.8.2.1 Type 1

2.8.2.2 Type 2

2.8.3 Lundbeck. Alzheimer’s Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.8.4 Business Overview

2.8.5 Lundbeck. News

3 North America Alzheimer’s Disease Drug Market Competition, by Manufacturer

3.1 North America Alzheimer’s Disease Drug Sales and Market Share by Manufacturer (2016-2017)

3.2 North America Alzheimer’s Disease Drug Revenue and Market Share by Manufacturer (2016-2017)

3.3 North America Alzheimer’s Disease Drug Price by Manufacturers (2016-2017)

3.4 Market Concentration Rate

3.4.1 Top 3 Alzheimer’s Disease Drug Manufacturer Market Share

3.4.2 Top 5 Alzheimer’s Disease Drug Manufacturer Market Share

3.5 Market Competition Trend

4 North America Alzheimer’s Disease Drug Market Analysis by Countries

4.1 North America Alzheimer’s Disease Drug Sales Market Share by Countries

4.2 North America Alzheimer’s Disease Drug Sales by Countries (2012-2017)

4.3 North America Alzheimer’s Disease Drug Revenue (Value) by Countries (2012-2017)

5 North America Market Segmentation Alzheimer’s Disease Drug by Type

5.1 North America Alzheimer’s Disease Drug Sales, Revenue and Market Share by Type (2012-2017)

5.1.1 North America Alzheimer’s Disease Drug Sales and Market Share by Type (2012-2017)

5.1.2 North America Alzheimer’s Disease Drug Revenue and Market Share by Type (2012-2017)

5.2 Donepezil Sales Growth and Price

5.2.1 North America Donepezil Sales Growth (2012-2017)

5.2.2 North America Donepezil Price (2012-2017)

5.3 Memantine Sales Growth and Price

5.3.1 North America Memantine Sales Growth (2012-2017)

5.3.2 North America Memantine Price (2012-2017)

5.4 Rivastigmine Sales Growth and Price

5.4.1 North America Rivastigmine Sales Growth (2012-2017)

5.4.2 North America Rivastigmine Price (2012-2017)

6 North America Market Segmentation Alzheimer’s Disease Drug by Application

6.1 North America Alzheimer’s Disease Drug Sales Market Share by Application (2012-2017)

6.2 Early to Moderate Stages Sales Growth (2012-2017)

6.3 Moderate to Severe Stages Sales Growth (2012-2017)

7 United States Alzheimer’s Disease Drug Sales, Revenue, by Type, Application and Manufacturers

7.1 United States Alzheimer’s Disease Drug Revenue, Sales and Growth Rate (2012-2017)

7.2 United States Alzheimer’s Disease Drug Sales and Market Share by Type

7.3 United States Alzheimer’s Disease Drug Sales by Application (2012-2017)

7.4 United States Alzheimer’s Disease Drug Sales, Revenue and Market Share by Manufacturer

7.4.1 United States Alzheimer’s Disease Drug Sales and Market Share by Manufacturer

7.4.2 United States Alzheimer’s Disease Drug Revenue and Market Share by Manufacturer

7.5 United States Alzheimer’s Disease Drug Export and Import (2012-2017)

8 Canada Alzheimer’s Disease Drug Sales, Revenue, by Type, Application and Manufacturers

8.1 Canada Alzheimer’s Disease Drug Revenue, Sales and Growth Rate (2012-2017)

8.2 Canada Alzheimer’s Disease Drug Sales and Market Share by Type

8.3 Canada Alzheimer’s Disease Drug Sales by Application (2012-2017)

8.4 Canada Alzheimer’s Disease Drug Sales, Revenue and Market Share by Manufacturer

8.4.1 Canada Alzheimer’s Disease Drug Sales and Market Share by Manufacturer

8.4.2 Canada Alzheimer’s Disease Drug Revenue and Market Share by Manufacturer

8.5 Canada Alzheimer’s Disease Drug Export and Import (2012-2017)

9 Mexico Alzheimer’s Disease Drug Sales, Revenue, by Type, Application and Manufacturers

9.1 Mexico Alzheimer’s Disease Drug Revenue, Sales and Growth Rate (2012-2017)

9.2 Mexico Alzheimer’s Disease Drug Sales and Market Share by Type

9.3 Mexico Alzheimer’s Disease Drug Sales by Application (2012-2017)

9.4 Mexico Alzheimer’s Disease Drug Sales, Revenue and Market Share by Manufacturer

9.4.1 Mexico Alzheimer’s Disease Drug Sales and Market Share by Manufacturer

9.4.2 Mexico Alzheimer’s Disease Drug Revenue and Market Share by Manufacturer

9.5 Mexico Alzheimer’s Disease Drug Export and Import (2012-2017)

10 Alzheimer’s Disease Drug Market Forecast (2017-2022)

10.1 North America Alzheimer’s Disease Drug Sales, Revenue and Growth Rate (2017-2022)

10.2 Alzheimer’s Disease Drug Market Forecast by Countries (2017-2022)

10.2.1 United States Alzheimer’s Disease Drug Forecast (2017-2022)

10.2.2 Canada Alzheimer’s Disease Drug Forecast (2017-2022)

10.2.3 Mexico Alzheimer’s Disease Drug Forecast (2017-2022)

10.3 Alzheimer’s Disease Drug Market Forecast by Type (2017-2022)

10.4 Alzheimer’s Disease Drug Market Forecast by Application (2017-2022)

11 Alzheimer’s Disease Drug Manufacturing Cost Analysis

11.1 Alzheimer’s Disease Drug Key Raw Materials Analysis

11.1.1 Key Raw Materials

11.1.2 Price Trend of Key Raw Materials

11.1.3 Key Suppliers of Raw Materials

11.1.4 Market Concentration Rate of Raw Materials

11.2 Proportion of Manufacturing Cost Structure

11.2.1 Raw Materials

11.2.2 Labor Cost

11.2.3 Manufacturing Expenses

11.3 Manufacturing Process Analysis of Alzheimer’s Disease Drug

12 Industrial Chain, Sourcing Strategy and Downstream Buyers

12.1 Alzheimer’s Disease Drug Industrial Chain Analysis

12.2 Upstream Raw Materials Sourcing

12.3 Raw Materials Sources of Alzheimer’s Disease Drug Major Manufacturers in 2016

12.4 Downstream Buyers

13 Sales Channel, Distributors, Traders and Dealers

13.1 Sales Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.1.3 Marketing Channel Future Trend

13.2 Distributors, Traders and Dealers

14 Research Findings and Conclusion

15 Appendix

15.1 Methodology

15.2 Analyst Introduction

15.3 Data SourceList of Tables and Figures

Figure Alzheimer’s Disease Drug Picture

Table Product Specifications of Alzheimer’s Disease Drug

Figure North America Sales Market Share of Alzheimer’s Disease Drug by Types in 2016

Table Types of Alzheimer’s Disease Drug

Figure Donepezil Picture

Table Major Manufacturers of Donepezil

Figure Memantine Picture

Table Major Manufacturers of Memantine

Figure Rivastigmine Picture

Table Major Manufacturers of Rivastigmine

Table North America Alzheimer’s Disease Drug Sales Market Share by Applications in 2016

Table Applications of Alzheimer’s Disease Drug

Figure Early to Moderate Stages Picture

Figure Moderate to Severe Stages Picture

Figure United States Alzheimer’s Disease Drug Revenue (Million USD) and Growth Rate (2012-2022)

Figure Mexico Alzheimer’s Disease Drug Revenue (Million USD) and Growth Rate (2012-2022)

Figure Canada Alzheimer’s Disease Drug Revenue (Million USD) and Growth Rate (2012-2022)

Table Allergan Basic Information, Manufacturing Base and Competitors

Table Allergan Alzheimer’s Disease Drug Type and Applications

Table Allergan Alzheimer’s Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Eisai Basic Information, Manufacturing Base and Competitors

Table Eisai Alzheimer’s Disease Drug Type and Applications

Table Eisai Alzheimer’s Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Novartis Basic Information, Manufacturing Base and Competitors

Table Novartis Alzheimer’s Disease Drug Type and Applications

Table Novartis Alzheimer’s Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Daiichi Sankyo Basic Information, Manufacturing Base and Competitors

Table Daiichi Sankyo Alzheimer’s Disease Drug Type and Applications

Table Daiichi Sankyo Alzheimer’s Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Merz Pharma Basic Information, Manufacturing Base and Competitors

Table Merz Pharma Alzheimer’s Disease Drug Type and Applications

Table Merz Pharma Alzheimer’s Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Pfizer Basic Information, Manufacturing Base and Competitors

Table Pfizer Alzheimer’s Disease Drug Type and Applications

Table Pfizer Alzheimer’s Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Johnson & Johnson Basic Information, Manufacturing Base and Competitors

Table Johnson & Johnson Alzheimer’s Disease Drug Type and Applications

Table Johnson & Johnson Alzheimer’s Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Lundbeck. Basic Information, Manufacturing Base and Competitors

Table Lundbeck. Alzheimer’s Disease Drug Type and Applications

Table Lundbeck. Alzheimer’s Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table North America Alzheimer’s Disease Drug Sales by Manufacturer (2016-2017)

Figure North America Alzheimer’s Disease Drug Sales Market Share by Manufacturer in 2016

Figure North America Alzheimer’s Disease Drug Sales Market Share by Manufacturer in 2017

Table North America Alzheimer’s Disease Drug Revenue by Manufacturer (2016-2017)

Figure North America Alzheimer’s Disease Drug Revenue Market Share by Manufacturer in 2016

Figure North America Alzheimer’s Disease Drug Revenue Market Share by Manufacturer in 2017

Table North America Alzheimer’s Disease Drug Price by Manufacturers (2016-2017)

Figure Top 3 Alzheimer’s Disease Drug Manufacturer Market Share in 2016

Figure Top 3 Alzheimer’s Disease Drug Manufacturer Market Share in 2017

Figure Top 5 Alzheimer’s Disease Drug Manufacturer Market Share in 2016

Figure Top 5 Alzheimer’s Disease Drug Manufacturer Market Share in 2017

Figure North America Alzheimer’s Disease Drug Sales and Growth (2012-2017)

Table North America Alzheimer’s Disease Drug Sales by Countries (2012-2017)

Table North America Alzheimer’s Disease Drug Sales Market Share by Countries (2012-2017)

Figure North America 2012 Alzheimer’s Disease Drug Sales Market Share by Countries

Figure North America 2016 Alzheimer’s Disease Drug Sales Market Share by Countries

Figure North America Alzheimer’s Disease Drug Revenue and Growth (2012-2017)

Table North America Alzheimer’s Disease Drug Revenue by Countries (2012-2017)

Table North America Alzheimer’s Disease Drug Revenue Market Share by Countries (2012-2017)

Table North America 2012 Alzheimer’s Disease Drug Revenue Market Share by Countries

Table North America 2016 Alzheimer’s Disease Drug Revenue Market Share by Countries

Table North America Alzheimer’s Disease Drug Sales by Type (2012-2017)

Table North America Alzheimer’s Disease Drug Sales Share by Type (2012-2017)

Table North America Alzheimer’s Disease Drug Revenue by Type (2012-2017)

Table North America Alzheimer’s Disease Drug Revenue Share by Type (2012-2017)

Figure North America Donepezil Sales Growth (2012-2017)

Figure North America Donepezil Price (2012-2017)

Figure North America Memantine Sales Growth (2012-2017)

Figure North America Memantine Price (2012-2017)

Figure North America Rivastigmine Sales Growth (2012-2017)

Figure North America Rivastigmine Price (2012-2017)

Table North America Alzheimer’s Disease Drug Sales by Application (2012-2017)

Table North America Alzheimer’s Disease Drug Sales Share by Application (2012-2017)

Figure North America Early to Moderate Stages Sales Growth (2012-2017)

Figure North America Moderate to Severe Stages Sales Growth (2012-2017)

Figure United States Alzheimer’s Disease Drug Revenue and Growth (2012-2017)

Figure United States Alzheimer’s Disease Drug Sales and Growth (2012-2017)

Table United States Alzheimer’s Disease Drug Sales by Type (2012-2017)

Table United States Alzheimer’s Disease Drug Sales Market Share by Type (2012-2017)

Table United States Alzheimer’s Disease Drug Sales by Application (2012-2017)

Table United States Alzheimer’s Disease Drug Sales Market Share by Application (2012-2017)

Table United States Alzheimer’s Disease Drug Sales by Manufacturer (2016-2017)

Figure United States Alzheimer’s Disease Drug Sales Market Share by Manufacturer in 2016

Figure United States Alzheimer’s Disease Drug Sales Market Share by Manufacturer in 2017

Table United States Alzheimer’s Disease Drug Revenue by Manufacturer (2016-2017)

Figure United States Alzheimer’s Disease Drug Revenue Market Share by Manufacturer in 2016

Figure United States Alzheimer’s Disease Drug Revenue Market Share by Manufacturer in 2017

Table United States Alzheimer’s Disease Drug Export and Import (2012-2017)

Figure Canada Alzheimer’s Disease Drug Revenue and Growth (2012-2017)

Figure Canada Alzheimer’s Disease Drug Sales and Growth (2012-2017)

Table Canada Alzheimer’s Disease Drug Sales by Type (2012-2017)

Table Canada Alzheimer’s Disease Drug Sales Market Share by Type (2012-2017)

Table Canada Alzheimer’s Disease Drug Sales by Application (2012-2017)

Table Canada Alzheimer’s Disease Drug Sales Market Share by Application (2012-2017)

Table Canada Alzheimer’s Disease Drug Sales by Manufacturer (2016-2017)

Figure Canada Alzheimer’s Disease Drug Sales Market Share by Manufacturer in 2016

Figure Canada Alzheimer’s Disease Drug Sales Market Share by Manufacturer in 2017

Table Canada Alzheimer’s Disease Drug Revenue by Manufacturer (2016-2017)

Figure Canada Alzheimer’s Disease Drug Revenue Market Share by Manufacturer in 2016

Figure Canada Alzheimer’s Disease Drug Revenue Market Share by Manufacturer in 2017

Table Canada Alzheimer’s Disease Drug Export and Import (2012-2017)

Figure Mexico Alzheimer’s Disease Drug Revenue and Growth (2012-2017)

Figure Mexico Alzheimer’s Disease Drug Sales and Growth (2012-2017)

Table Mexico Alzheimer’s Disease Drug Sales by Type (2012-2017)

Table Mexico Alzheimer’s Disease Drug Sales Market Share by Type (2012-2017)

Table Mexico Alzheimer’s Disease Drug Sales by Application (2012-2017)

Table Mexico Alzheimer’s Disease Drug Sales Market Share by Application (2012-2017)

Table Mexico Alzheimer’s Disease Drug Sales by Manufacturer (2016-2017)

Figure Mexico Alzheimer’s Disease Drug Sales Market Share by Manufacturer in 2016

Figure Mexico Alzheimer’s Disease Drug Sales Market Share by Manufacturer in 2017

Table Mexico Alzheimer’s Disease Drug Revenue by Manufacturer (2016-2017)

Figure Mexico Alzheimer’s Disease Drug Revenue Market Share by Manufacturer in 2016

Figure Mexico Alzheimer’s Disease Drug Revenue Market Share by Manufacturer in 2017

Table Mexico Alzheimer’s Disease Drug Export and Import (2012-2017)

Figure North America Alzheimer’s Disease Drug Sales, Revenue and Growth Rate (2017-2022)

Table North America Alzheimer’s Disease Drug Sales Forecast by Countries (2017-2022)

Table North America Alzheimer’s Disease Drug Market Share Forecast by Countries (2017-2022)

Figure United States Alzheimer’s Disease Drug Sales Forecast (2017-2022)

Figure Canada Alzheimer’s Disease Drug Sales Forecast (2017-2022)

Figure Mexico Alzheimer’s Disease Drug Sales Forecast (2017-2022)

Table North America Alzheimer’s Disease Drug Sales Forecast by Type (2017-2022)

Table North America Alzheimer’s Disease Drug Market Share Forecast by Type (2017-2022)

Table North America Alzheimer’s Disease Drug Sales Forecast by Application (2017-2022)

Table North America Alzheimer’s Disease Drug Market Share Forecast by Application (2017-2022)

Table Sales Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Alzheimer’s Disease Drug

Figure Manufacturing Process Analysis of Alzheimer’s Disease Drug

Figure Alzheimer’s Disease Drug Industrial Chain Analysis

Table Raw Materials Sources of Alzheimer’s Disease Drug Major Manufacturers in 2016

Table Major Buyers of Alzheimer’s Disease Drug

Table Distributors/Traders/ Dealers List